Capital Fund Management (CFM)
DXCM icon

Capital Fund Management (CFM)’s DexCom DXCM Stock Holding History

Capital Fund Management (CFM)’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-42,800
Closed -$2.84M – 2185
2025
Q4 		$2.84M Buy
42,800
+30,300
+242% +$1.96M 0.01% 1521
2025
Q3 		$841K Sell
12,500
-59,800
-83% -$4.73M ﹤0.01% 2163
2025
Q2 		$6.31M Buy
72,300
+16,500
+30% +$1.29M 0.02% 999
2025
Q1 		$3.81M Sell
55,800
-171,000
-75% -$14M 0.01% 1144
2024
Q4 		$17.6M Buy
226,800
+102,800
+83% +$7.61M 0.05% 527
2024
Q3 		$8.31M Buy
124,000
+17,700
+17% +$1.45M 0.02% 791
2024
Q2 		$12.1M Sell
106,300
-122,500
-54% -$15.5M 0.04% 595
2024
Q1 		$31.7M Sell
228,800
-415,300
-64% -$52.2M 0.09% 292
2023
Q4 		$79.9M Buy
644,100
+318,700
+98% +$32.6M 0.21% 108
2023
Q3 		$30.4M Buy
325,400
+76,700
+31% +$8.65M 0.1% 251
2023
Q2 		$32M Buy
+248,700
New +$30.1M 0.13% 206
2023
Q1 		– Sell
-22,300
Closed -$2.53M – 1607
2022
Q4 		$2.53M Sell
22,300
-200
-0.9% -$22K 0.02% 849
2022
Q3 		$1.81M Sell
22,500
-38,500
-63% -$3.26M 0.01% 890
2022
Q2 		$4.55M Buy
+61,000
New +$5.57M 0.04% 535
2019
Q3 		– Sell
-35,200
Closed -$1.32M – 1709
2019
Q2 		$1.32M Buy
+35,200
New +$1.11M 0.01% 925
2018
Q4 		– Sell
-9,200
Closed -$329K – 1932
2018
Q3 		$329K Sell
9,200
-36,400
-80% -$1.13M ﹤0.01% 1731
2018
Q2 		$1.08M Buy
+45,600
New +$967K 0.01% 1300
2016
Q1 		– Sell
-15,600
Closed -$319K – 1590
2015
Q4 		$319K Sell
15,600
-6,400
-29% -$133K ﹤0.01% 1285
2015
Q3 		$472K Sell
22,000
-3,600
-14% -$80.3K 0.01% 1056
2015
Q2 		$512K Buy
+25,600
New +$450K 0.01% 1067

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Fund Management (CFM)'s DXCM Position: Q2 2026 in Review

Capital Fund Management (CFM) increased its DexCom (DXCM) stake by 24% in Q2 2026, buying an estimated $8.59M and bringing the position to 661,379 shares worth $44.5M. The position accounts for 0.2% of the portfolio, ranked #104.

Capital Fund Management (CFM) first reported a position in DXCM in Q1 2014 and has held it in 31 quarters since. The position peaked at $53.8M in Q4 2024. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Capital Fund Management (CFM) held 661,379 shares of DexCom worth $44.5M as of Q2 2026.
  • Capital Fund Management (CFM) bought 128,983 DexCom shares in Q2 2026, an estimated $8.59M.
  • DexCom made up 0.2% of Capital Fund Management (CFM)'s portfolio in Q2 2026, its #104 holding.
  • Capital Fund Management (CFM) first reported a position in DexCom in Q1 2014 and has held it in 31 quarters since.
  • Capital Fund Management (CFM)'s DexCom position peaked at $53.8M in Q4 2024.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Capital Fund Management (CFM)'s 13F filing for Q2 2026, filed 13 Aug 2026.